| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5857236 | Regulatory Toxicology and Pharmacology | 2012 | 9 Pages |
Abstract
⺠The number of incidents associated with GHB proved to be relatively high. ⺠Repeatedly 'passing out' due to GHB may impair cognition and memory. ⺠The prevalence of GHB use is relatively low and treatment demand is small. ⺠The overall risk potential of GHB use estimated as moderate to high. ⺠Based on this assessment GHB was categorized in the Netherlands as a hard drug.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Jan G.C. van Amsterdam, Margriet van Laar, Tibor M. Brunt, Wim van den Brink,